8-KLeadership ChangesExhibits & Filings

INTEL CORP 8-K Report, Executive Changes (Aug 14, 2020)

Filed August 14, 2020For Securities:INTC

Summary

Intel Corporation (INTC) filed an 8-K report on August 13, 2020, detailing the departure of Dr. Venkata Renduchintala, effective August 3, 2020. This departure marks a significant change in leadership, as Dr. Renduchintala held a key executive role within the company. In connection with his separation, Intel entered into a Separation Agreement and General Release of Claims with Dr. Renduchintala. This agreement outlines the terms of his exit, including a separation payment of $1,800,000 and other benefits. Dr. Renduchintala has also reconfirmed his obligations regarding confidentiality, intellectual property, non-disparagement, and cooperation with Intel. Investors should monitor the impact of this executive transition on the company's strategic direction and operational execution.

Key Highlights

  • 1Dr. Venkata Renduchintala departed Intel effective August 3, 2020.
  • 2A Separation Agreement and General Release of Claims was executed on August 11, 2020.
  • 3Dr. Renduchintala will receive a separation payment of $1,800,000.
  • 4The agreement includes customary releases in favor of Intel.
  • 5Dr. Renduchintala reconfirmed his obligations concerning confidentiality and intellectual property.
  • 6The agreement also includes non-disparagement and cooperation provisions.

Frequently Asked Questions

Dr. Venkata Renduchintala was a key executive at Intel. While the 8-K doesn't specify his exact title, his departure is listed under Item 5.02, which typically concerns significant officers.

The direct financial impact disclosed in this filing is the $1,800,000 separation payment made to Dr. Renduchintala. Any broader impact on operations or future performance is not detailed in this specific 8-K filing.

The agreement includes a $1.8 million payment, other benefits, a release of claims by Dr. Renduchintala in favor of Intel, and confirmation of his obligations regarding confidentiality, intellectual property, non-disparagement, and cooperation.

The 8-K filing states that Dr. Renduchintala departed Intel, but it does not provide specific reasons for his departure. The focus of this report is on the terms of his separation.